WADA moves to ban tramadol in competition starting in 2024

Nairo Quintana is refuting a positive tramadol test from the Col du Granon stage of the Tour de France, pictured here
Nairo Quintana is refuting a positive tramadol test from the Col du Granon stage of the Tour de France, pictured here (Image credit: Getty Images Sport)

The World Anti-Doping Agency moved to ban the opioid painkiller tramadol in competition from 2024 onward during the meeting of the Executive Committee in Sydney this week.

Tramadol is already prohibited in competition under UCI anti-doping rules, a provision that caught out Nairo Quintana (Arkéa-Samsic) in testing during the 2022 Tour de France.

Laura Weislo
Managing Editor

Laura Weislo has been with Cyclingnews since 2006 after making a switch from a career in science. As Managing Editor, she coordinates coverage for North American events and global news. As former elite-level road racer who dabbled in cyclo-cross and track, Laura has a passion for all three disciplines. When not working she likes to go camping and explore lesser traveled roads, paths and gravel tracks. Laura specialises in covering doping, anti-doping, UCI governance and performing data analysis.